When metallic objects change their shape seemingly without any external influence and only according to the will of their owners, this at first sounds like something only comic superheroes like Magneto and Ironman could do. However, the idea from those comics has a real-world manifestation in existing materials called magnetic shape memory alloys (MSMAs). Moreover, they have potential applications e.g. in robotics or medical devices.
Scientists at the Institut Laue-Langevin (ILL), in collaboration with the Paul Scherrer Institut (PSI), the Institut de Biologie Structurale (IBS) and the Australian Nuclear Science and Technology Organisation (ANSTO), have published new data on how the SARS-CoV-2 spike protein interacts with mammalian lung cell membranes allowing the viral RNA to enter human cells.
Key ingredients in toothpastes and mouthwashes can occasionally act as irritants to the inside of the mouth. By looking at the way these ingredients interact with thin films of spit, researchers hope to develop new, less irritant, formations.
Significant amounts of antibiotic residues and pathogens enter the environment via our wastewater. A German Italian team of researchers has now investigated a novel nanomaterial that has an antibacterial effect and can bind antibiotics at the Heinz Maier-Leibnitz Zentrum. Wastewater could thus be treated more effectively and safely.
Depressive disorders are among the most frequent illnesses worldwide. The causes are complex and to date only partially understood. The trace element lithium appears to play a role. Using neutrons of the research neutron source at the Technical University of Munich (TUM), a research team has now proved that the distribution of lithium in the brains of depressive people is different from the distribution found in healthy humans.
From Contrast Agents to Drug Delivery: Research with Neutrons Enables Advances in Biomedical Research
Biocompatible iron oxide nanoparticles (IONPs) offer great potential for biomedical applications, both in terms of imaging and therapy. More rapid progress in researching IONPs now looks promising by using a new method combination developed by a team of Jülich researchers using neutrons as a probe.
Neutron reflectometry has given scientists an atomic-level insight into the behaviour of Bcl-2, a protein that promotes cancerous cell growth.
In December 2020, the Pfizer-BioNTech COVID-19 vaccine was approved for use across the EU, marking a crucial step forward in the fight against coronavirus. The development of this COVID-19 vaccine built on important research that was undertaken by Mainz-based biotechnology company, BioNTech, in collaboration with the Jülich Center for Neutron Science (JCNS). Using neutron scattering instruments operated by the JCNS at the Heinz Maier-Leibnitz Center in Garching, researchers investigated new approaches for the packaging and delivery of the mRNA. Such experiments provide important insights into the relationship between structural properties, biological activity and the vaccine production process, which will help to advance the development of RNA therapeutics and vaccines.